key: cord-1034061-9rflivnz
authors: Verdura, Vincenzo; Di Pace, Bruno; Cagiano, Luigi; Portincasa, Aurelio
title: Home Wound Management during the COVID-19 Pandemic: the Use of a Novel Adhesive Retention Suture
date: 2021-01-23
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.01.008
sha: f168326cca6963c5716046216551cb91bdf2a341
doc_id: 1034061
cord_uid: 9rflivnz

nan

Dear Editor, 1

We read with great interest the noteworthy contribution on skin management cancer in times of the 2 Sars-Cov2 infection by Roybal et al. 1 regarding the efforts made during the current pandemic aimed at 3 reducing contact times and follow-up visits through the use of adhesive retention sutures (ARS) for wound 4 closure. 5

As for avoiding diagnosis delay and subsequent treatment of skin cancers, national and international 6 guidance to optimize the management of these patients has been provided. BAPRAS has drawn up a detailed 7 management protocol and the NCCN has modified the existing guidelines to adapt the timing and treatment 8 options. 2,3 9

Most of our patients are elderly and frequently have significant coexisting comorbidities and this 10 combination of conditions often makes post-surgical management of the patient challenging. However, the 11 use of absorbable sutures, cyanoacrylate glues and restraint devices provide excellent solutions for easier 12 post-surgical management. Despite the fact that our patient cohort would likely need a degree of personal 13 assistance due to potential limited mental faculty or dexterity, in the current circumstances it would be 14 appropriate to reduce the risk of contagion by opting for home management. 15

Indeed, we particularly appreciated your ARS device which, in addition to the above mentioned 16 practical solutions, addresses the problem related to the closure of large substance loss. The technical-17 practical goal is to reconstruct the loss of residual substance without resorting to flaps, grafts or dermal 18 substitutes that would significantly prolong post-operative management. In particular, the application of 19

Nylon 2-0 in the middle of the surgical wound aims to reduce the deep tension that other devices are not 20 usually able to do. 21

However, while the ARS in our experience resulted in satisfactory results for the loss of substance in 22 the trunk and lower limbs, it led to a less satisfactory aesthetic result for the loss of substance on the face. In 23 particular, the apposition of a transfixed central suture represents an additional scar on both sides of the 24 wound. This result is particularly evident and not easily accepted by the patient since it is well beyond the 25 subcutaneous sutures and then a superficial restraint system by means of adhesives. 27 A further challenge relating to the home management of ARS, which the authors failed to mention, is 28 that the home removal of the central point does not require strict compliance, as per good clinical practice, 29

with the management protocols of surgical wounds. Indeed, it should be ensured that the removal of the 30 stitch is carried out either with sterile instruments (where possible) or by recommending practical solutions 31 for home sterilization (immerging scissors in boiling water for at least 5 minutes or cleaning with 32 iodopovidone). In fact, we would also suggest providing practical guidance on how to cut the suture at the 33 short segment exposed to avoid contamination of the wound. Overall, adopting remote consultation for 34 wound management of your cases is advisable in these trying times. 35

Use of a novel adhesive suture retention 38 wound closure device to prevent patient follow-up visits during the COVID-19 pandemic

British Association of Plastic, Reconstructive and Aesthetic Surgeons

SCC patients during Coronavirus pandemic

National Comprehensive Cancer Network. Coronavirus Disease 2019 (COVID-19) Resources for the 44